FDA Warns of Cardiac Effect When Heart Drug Mixed With Hepatitis C Meds

March 25, 2015 6:00 PM

4 0

WEDNESDAY, March 25, 2015 (HealthDay News) -- A potentially life-threatening slowing of the heart can occur when the common heart drug amiodarone is taken with new hepatitis C medications, the U.S. Food and Drug Administration warns.

The dangerous slowing of the heart -- called symptomatic bradycardia -- can occur when amiodarone is taken with the hepatitis C drugs Harvoni (ledipasvir/sofosbuvir) or Sovaldi (sofosbuvir) and combined with another direct-acting antiviral for the treatment of hepatitis C.

Read more

To category page